Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 4 1

Status

Completed 4Unknown 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Dermatologic 1

Conditions

Motor Activity 1Melanoma 1Liver Neoplasms 1Hyperphagia 1Fibrosis 1Disease Progression 1Carcinoma, Ovarian Epithelial 1

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 330Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 281Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × OTHER × Clinical Trials as Topic × Clear all
NCT02645149 2026-05-29

Match Mel

Melanoma Institute Australia

Phase 2 Completed
216 enrolled
Dermatologic

Melanoma

NCT02376231 2019-09-26

PJEOC

Royal Surrey County Hospital NHS Foundation Trust

Phase NA Completed
120 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial

NCT02321202 2018-08-22

Omega-3 Fatty Acid-Based Parenteral Nutrition Improves Postoperative Recovery for Cirrhotic Patients With Liver Cancer

Huazhong University of Science and Technology

Phase 4 Completed
320 enrolled
Gastrointestinal

Fibrosis, Hyperphagia, Liver Neoplasms, Disease Progression

NCT01571401 2013-06-19

TRACKS

University of Alberta

Phase 2 Completed
32 enrolled

Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡